Search Result "prolactinoma."
Autoimmune Fibrotic Adverse Reactions in One-Year Treatment with Cabergoline for Women with Prolactinoma
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 16 Issue: 1 Year: 2016 Page: 47-55
Author(s): Berçem Ayçiçek DoÄan,Ayse Arduc,Mazhar Müslüm Tuna,Dilek Berker,Nilgün Demirci,Semra DemirtaÅ,Hülya ÃiçekcioÄlu,Serdar Güler
Gender Differences in Patients with Prolactinoma: Single-centerUkrainian Experience
Journal: Reviews on Recent Clinical Trials
Volume: 19 Issue: 3 Year: 2024 Page: 204-214
Author(s):
Italian Guidelines for the Management of Prolactinomas
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 23 Issue: 12 Year: 2023 Page: 1459-1479
Author(s): Andrea Gerardo Lania
Different Cabergoline Effect on Metabolic and Anthropometric Parameters in Female Prolactinoma Patients Versus Idiopathic Hyperprolactinemia Patients
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 19 Issue: 4 Year: 2019 Page: 511-518
Author(s): Mohamed M. Aboelnaga,Eman H. Eladawy,Maha M. Elshafei,Nahed Abdullah,Moustafa El. Shaer
Frequency of Pituitary Tumor Apoplexy During Treatment of Prolactinomas with Dopamine Agonists: A Systematic Review
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11 Issue: 8 Year: 2012 Page: 1012-1014
Author(s): Robert Carija,Diana Vucina
IGF-1 Gene Therapy as a Potentially Useful Therapy for Spontaneous Prolactinomas in Senile Rats
Journal: Current Gene Therapy
Volume: 18 Issue: 4 Year: 2018 Page: 240-245
Author(s): Oscar A. Brown,Martina Canatelli-Mallat,Gloria M. Console,Gisela Camihort,Georgina Luna,Eduardo Spinedi,Rodolfo G. Goya
25-hydroxyvitamin D Correlation with Prolactin Levels and Adenoma Size in Female Patients with Newly Diagnosed Prolactin Secreting Adenoma
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 17 Issue: 3 Year: 2017 Page: 219-225
Author(s): Mohamed M. Aboelnaga,Nahed Abdullah,Mostafa El Shaer
Potential of Gene Therapy for the Treatment of Pituitary Tumors
Journal: Current Gene Therapy
Volume: 4 Issue: 1 Year: 2004 Page: 79-87
Author(s): R. G. Goya, D. K. Sarkar, O. A. Brown, C. B. Herenu
A Novel Marine Drug, SZ–685C, Induces Apoptosis of MMQ Pituitary Tumor Cells by Downregulating miR–200c
Journal: Current Medicinal Chemistry
Volume: 20 Issue: 1 Year: 2013 Page: 2145-2154
Author(s): C.–H. Chen, W.–W. Xiao, X.–B. Jiang, J.–W. Wang, Z.–G. Mao, N. Lei, X. Fan, B.–B. Song, C.–X. Liao, H.–J. Wang, Z.–G. She, Y.–H. Zhu
Signaling Processes in Tumoral Neuroendocrine Pituitary Cells as Potential Targets for Therapeutic Drugs
Journal: Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume: 5 Issue: 3 Year: 2005 Page: 259-267
Author(s): M. Paez-Pereda, D. Giacomini, C. Echenique, G. K. Stalla, F. Holsboer, E. Arzt